[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@SyntaraTx](/creator/twitter/SyntaraTx) "Investor Presentation E&P Small Cap Healthcare Conference: September 2025 View the full $SNT Presentation here: #SNT #Syntara #ASX #Biotech #Healthcare" [X Link](https://x.com/SyntaraTx/status/1965200209937592329) [@SyntaraTx](/creator/x/SyntaraTx) 2025-09-08T23:46Z XXX followers, XXX engagements "We have received our R&D tax incentive of A$5606311 for eligible activities conducted during the 2025 financial year: The research incentive provides non-dilutive funding allowing us to further our programs while maintaining financial flexibility. $SNT" [X Link](https://x.com/SyntaraTx/status/1971065831187775657) [@SyntaraTx](/creator/x/SyntaraTx) 2025-09-25T04:14Z XXX followers, XXX engagements "Positive final Phase 2a amsulostat data webinar presentation- September 2025 View the $SNT presentation here: #SNT #Syntara #Biotech #ASX #ASXNews" [X Link](https://x.com/SyntaraTx/status/1972811618317902090) [@SyntaraTx](/creator/x/SyntaraTx) 2025-09-29T23:51Z XXX followers, XXX engagements "Investor Presentation: HK Ignite Investment Summit View the full $SNT Presentation here: #Biotech #myelofibrosis #bloodcancer #skinscarring" [X Link](https://x.com/SyntaraTx/status/1978222975834087444) [@SyntaraTx](/creator/x/SyntaraTx) 2025-10-14T22:14Z XXX followers, XX engagements "Our CEO Gary Phillips presented to investors at the Ignite Investment Summit in Hong Kong this week. Gary outlined our 52-week data for amsulostat in myelofibrosis showing sustained clinical improvement and an excellent safety profile reinforcing its potential as a meaningful new treatment option for patients. He also discussed the companys expanding blood cancer development pipeline and our upcoming milestones that positions Syntara for continued value creation over the next 12-18 months. Thank you to the Ignite team and attendees for the opportunity to share our story. $SNT #ASX #Biotech" [X Link](https://x.com/SyntaraTx/status/1978941542472781932) [@SyntaraTx](/creator/x/SyntaraTx) 2025-10-16T21:50Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SyntaraTx
"Investor Presentation E&P Small Cap Healthcare Conference: September 2025 View the full $SNT Presentation here: #SNT #Syntara #ASX #Biotech #Healthcare"
X Link @SyntaraTx 2025-09-08T23:46Z XXX followers, XXX engagements
"We have received our R&D tax incentive of A$5606311 for eligible activities conducted during the 2025 financial year: The research incentive provides non-dilutive funding allowing us to further our programs while maintaining financial flexibility. $SNT"
X Link @SyntaraTx 2025-09-25T04:14Z XXX followers, XXX engagements
"Positive final Phase 2a amsulostat data webinar presentation- September 2025 View the $SNT presentation here: #SNT #Syntara #Biotech #ASX #ASXNews"
X Link @SyntaraTx 2025-09-29T23:51Z XXX followers, XXX engagements
"Investor Presentation: HK Ignite Investment Summit View the full $SNT Presentation here: #Biotech #myelofibrosis #bloodcancer #skinscarring"
X Link @SyntaraTx 2025-10-14T22:14Z XXX followers, XX engagements
"Our CEO Gary Phillips presented to investors at the Ignite Investment Summit in Hong Kong this week. Gary outlined our 52-week data for amsulostat in myelofibrosis showing sustained clinical improvement and an excellent safety profile reinforcing its potential as a meaningful new treatment option for patients. He also discussed the companys expanding blood cancer development pipeline and our upcoming milestones that positions Syntara for continued value creation over the next 12-18 months. Thank you to the Ignite team and attendees for the opportunity to share our story. $SNT #ASX #Biotech"
X Link @SyntaraTx 2025-10-16T21:50Z XXX followers, XX engagements
/creator/twitter::66560841/posts